Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-022826-34Phase 4Active
Phase 4, randomised trial of phytomenadione in Vitamin K antagonist over-anticoagulation and reversal of vitamin K antagonist effect before invasive procedure (2 arms). Primary endpoints: Primary bioavailability endpoint and Primary effectiveness endpoint. Started Sep 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-022826-34.